Table 3.
Information | Source(s) or program(s) used |
---|---|
Structural information | |
Tertiary structures | [22-24] |
Pockets on PPI interface | [25] |
Volume | [6,25] |
Accessible surface area | [6,25] |
Compactness | [6] |
Planarity | [6] |
Narrowness | [6] |
Curvature | [26] |
Roughness | [26] |
Amino acid composition | [6,24,25,27] |
Domains | [28,29] |
Disordered regions | [37] |
Amino acid sequence motifs | [38,39] |
Drug/chemical information | |
FDA-approved drugs | [40] |
Chemicals associated with interacting proteins | [41] |
Functional information | |
Human diseases in OMIM | [42] |
Number of interacting proteins in PPI network | [6] |
Biological pathways | [43,44] |
GO terms and identity scores of GO terms | [6,45] |
Gene expression profiles and similarity scores of profiles | [6,46] |
Paralogs | [43,47] |